These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33927317)

  • 1. Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stages.
    Amboni M; Ricciardi C; Picillo M; De Santis C; Ricciardelli G; Abate F; Tepedino MF; D'Addio G; Cesarelli G; Volpe G; Calabrese MC; Cesarelli M; Barone P
    Sci Rep; 2021 Apr; 11(1):9297. PubMed ID: 33927317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning.
    De Vos M; Prince J; Buchanan T; FitzGerald JJ; Antoniades CA
    Gait Posture; 2020 Mar; 77():257-263. PubMed ID: 32078894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ratio of square wave jerk rates to blink rates distinguishes progressive supranuclear palsy from Parkinson disease.
    Altiparmak UE; Eggenberger E; Coleman A; Condon K
    J Neuroophthalmol; 2006 Dec; 26(4):257-9. PubMed ID: 17204917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
    Pagonabarraga J; Horta-Barba A; Busteed L; Bejr-Kasem H; Illán-Gala I; Aracil-Bolaños I; Marín-Lahoz J; Pascual-Sedano B; Pérez J; Campolongo A; Izquierdo C; Martinez-Horta S; Sampedro F; Kulisevsky J
    Parkinsonism Relat Disord; 2021 Apr; 85():63-68. PubMed ID: 33744691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminating features of gait performance in progressive supranuclear palsy.
    Amano S; Skinner JW; Lee HK; Stegemöller EL; Hack N; Akbar U; Vaillancourt D; McFarland NR; Hass CJ
    Parkinsonism Relat Disord; 2015 Aug; 21(8):888-93. PubMed ID: 26032992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy.
    Neely KA; Planetta PJ; Prodoehl J; Corcos DM; Comella CL; Goetz CG; Shannon KL; Vaillancourt DE
    PLoS One; 2013; 8(3):e58403. PubMed ID: 23505500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.
    Seppi K; Schocke MF; Esterhammer R; Kremser C; Brenneis C; Mueller J; Boesch S; Jaschke W; Poewe W; Wenning GK
    Neurology; 2003 Mar; 60(6):922-7. PubMed ID: 12654954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating progressive supranuclear palsy from Parkinson's disease by MRI-based dynamic cerebrospinal fluid flow.
    Fukui Y; Hishikawa N; Sato K; Yunoki T; Kono S; Matsuzono K; Nakano Y; Ohta Y; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2015 Oct; 357(1-2):178-82. PubMed ID: 26227830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gait analysis in PSP and NPH: Dual-task conditions make the difference.
    Selge C; Schoeberl F; Zwergal A; Nuebling G; Brandt T; Dieterich M; Schniepp R; Jahn K
    Neurology; 2018 Mar; 90(12):e1021-e1028. PubMed ID: 29467306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote at-home wearable-based gait assessments in Progressive Supranuclear Palsy compared to Parkinson's Disease.
    Sharma M; Mishra RK; Hall AJ; Casado J; Cole R; Nunes AS; Barchard G; Vaziri A; Pantelyat A; Wills AM
    BMC Neurol; 2023 Dec; 23(1):434. PubMed ID: 38082255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study.
    Quattrone A; Morelli M; Vescio B; Nigro S; Le Piane E; Sabatini U; Caracciolo M; Vescio V; Quattrone A; Barbagallo G; Stanà C; Nicoletti G; Arabia G; Nisticò R; Novellino F; Salsone M
    Mov Disord; 2019 Apr; 34(4):487-495. PubMed ID: 30759325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
    Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O
    Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study.
    Painous C; Martí MJ; Simonet C; Garrido A; Valldeoriola F; Muñoz E; Cámara A; Compta Y
    Parkinsonism Relat Disord; 2020 May; 74():67-73. PubMed ID: 32536421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A network approach to diagnostic biomarkers in progressive supranuclear palsy.
    Santiago JA; Potashkin JA
    Mov Disord; 2014 Apr; 29(4):550-5. PubMed ID: 24347522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.